Express Eingabe
Austria
AuftragsverfolgungKontakt
Anti-EIF4E2 Rabbit Polyclonal Antibody | Avantor

Anti-EIF4E2 Rabbit Polyclonal Antibody

100 µg
Artikelnr. PRSI29-341
Anbieter:   ProSci Inc.
Anti-EIF4E2 Rabbit Polyclonal Antibody
Artikelnr. PRSI29-341
Anbieter:  ProSci Inc.
Anti-EIF4E2 Rabbit Polyclonal Antibody
Anti-EIF4E2 Rabbit Polyclonal Antibody

100 µg

Preis
525,00 €
Einloggen für Verfügbarkeit
1 * 100 µG
Product Details & Documents

EIF4E2 belongs to the eukaryotic initiation factor 4E family. It recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures.

Antibody is purified by protein A chromatography method.

Antibody is lyophilized in PBS buffer with 2% sucrose. Add 100 μL of distilled water. Final antibody concentration is 1 mg/mL.

Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.

Type:
Antigen: EIF4E2
Clonality: Polyclonal
Clone:
Conjugation: Unconjugated
Epitope:
Host: Rabbit
Isotype:
Reactivity: Human

Dokumente

Spezifikationen
  • Größe:
    100 µg
  • ImmunoChemie:
    Yes
  • Western blot:
    Yes
  • Cat. No.:
    PRSI29-341
  • Konjugation:
    Unconjugated
  • Form:
    Lyophilized
  • Immunogen:
    A synthetic peptide corresponding a region of human EIF4E2.
  • Reaktivität:
    Human
  • Antigen-Synonyme:
    mRNA cap-binding protein 4EHP|EIF4E2|mRNA cap-binding protein type 3|eIF-4E type 2|eIF4E-like protein 4E-LP|EIF4EL3|Eukaryotic translation initiation factor 4E type 2|Eukaryotic translation initiation factor 4E-like 3|eIF4E type 2|Eukaryotic translation initiation factor 4E homologous protein
  • Antigen-Symbol:
    EIF4E2
  • Klonalität:
    Polyklonal
  • Wirt:
    Rabbit
  • ELISA:
    Yes
Recommendations

Recommendations will be personalized based on your shopping preferences only if you have given your consent by enabling "Enhance my Shopping Experience" on the "Personal Info page".

Otherwise, you will receive generic recommendations.